Harvard Management as of June 30, 2021
Portfolio Holdings for Harvard Management
Harvard Management holds 38 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apple (AAPL) | 19.2 | $334M | 2.4M | 136.96 | |
| Royalty Pharma Shs Class A (RPRX) | 16.8 | $293M | 7.1M | 40.99 | |
| Scientific Games (LNW) | 11.9 | $207M | 2.7M | 77.44 | |
| Facebook Cl A (META) | 10.4 | $181M | 520k | 347.71 | |
| Palo Alto Networks (PANW) | 5.3 | $91M | 246k | 371.05 | |
| Abcellera Biologics (ABCL) | 5.2 | $90M | 4.1M | 22.00 | |
| Intercontinental Exchange (ICE) | 4.7 | $82M | 689k | 118.70 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 3.2 | $55M | 1.5M | 36.50 | |
| DaVita (DVA) | 2.8 | $49M | 409k | 120.43 | |
| 10x Genomics Cl A Com (TXG) | 2.1 | $37M | 186k | 195.82 | |
| Invesco Qqq Tr Unit Ser 1 (QQQ) | 2.1 | $36M | 102k | 354.43 | |
| Affirm Hldgs Com Cl A (AFRM) | 1.9 | $32M | 477k | 67.35 | |
| Ishares Tr Core S&p500 Etf (IVV) | 1.6 | $28M | 65k | 429.92 | |
| Purecycle Technologies (PCT) | 1.5 | $25M | 1.1M | 23.65 | |
| Revolution Medicines (RVMD) | 1.2 | $21M | 670k | 31.74 | |
| Unity Software (U) | 1.2 | $21M | 186k | 109.83 | |
| Relay Therapeutics (RLAY) | 1.1 | $20M | 541k | 36.59 | |
| Pliant Therapeutics (PLRX) | 0.9 | $16M | 562k | 29.12 | |
| Spdr Gold Tr Gold Shs (GLD) | 0.9 | $15M | 92k | 165.64 | |
| Praxis Precision Medicines I | 0.8 | $14M | 779k | 18.28 | |
| Generation Bio (GBIO) | 0.8 | $14M | 512k | 26.90 | |
| Kinnate Biopharma (KNTE) | 0.7 | $12M | 498k | 23.28 | |
| Sana Biotechnology (SANA) | 0.5 | $9.2M | 469k | 19.66 | |
| Vanguard Tax-managed Intl Ftse Dev Mkt Etf (VEA) | 0.5 | $8.4M | 163k | 51.52 | |
| Nurix Therapeutics (NRIX) | 0.5 | $8.4M | 315k | 26.53 | |
| Ishares Tr Core S&p Scp Etf (IJR) | 0.3 | $5.7M | 51k | 112.99 | |
| Fulcrum Therapeutics (FULC) | 0.2 | $4.3M | 411k | 10.48 | |
| Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO) | 0.2 | $4.0M | 74k | 54.31 | |
| Fs Development Corp Ii Com Cl A | 0.2 | $4.0M | 400k | 10.00 | |
| Ishares Tr Core S&p Mcp Etf (IJH) | 0.2 | $3.4M | 13k | 268.71 | |
| Magenta Therapeutics | 0.2 | $3.3M | 333k | 9.78 | |
| Pinduoduo Sponsored Ads (PDD) | 0.2 | $3.2M | 26k | 127.02 | |
| Seres Therapeutics (MCRB) | 0.2 | $3.1M | 132k | 23.85 | |
| Decibel Therapeutics | 0.2 | $2.8M | 329k | 8.60 | |
| Dyne Therapeutics (DYN) | 0.1 | $2.3M | 107k | 21.04 | |
| Gemini Therapeutics | 0.1 | $1.6M | 250k | 6.47 | |
| Nucana Sponsored Adr (NCNA) | 0.1 | $1.1M | 387k | 2.77 | |
| Cortexyme (QNCX) | 0.0 | $156k | 2.9k | 53.12 |
